Literature DB >> 17294233

Proteinase-activated receptors in the lower urinary tract.

James D Moffatt1.   

Abstract

Proteinase-activated receptors (PARs) are G-protein-coupled receptors that convert specific extracellular proteolytic activity into intracellular signals, and have been suggested to play diverse roles in the body. In this review, evidence for the roles of PARs in bladder contractility and inflammation are presented. The role of PARs in prostate cancer is also reviewed. The existing literature in this area can be difficult to interpret due to the many nonspecific actions of the pharmacological tools employed. Although there are reports that PAR activators can cause contraction of bladder smooth muscle, further pharmacological and molecular studies are required to define roles for these receptors in bladder contractility. While structural studies suggest that roles for PARs in bladder inflammation are likely, few functional investigations have been performed. The significance of the expression of PARs on sensory nerves innervating the bladder and changes in receptor expression in inflammatory disease models are fascinating areas for future research. Finally, it seems probable that PARs, particularly PAR1, may play important roles in the growth and metastasis of prostate cancers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17294233     DOI: 10.1007/s00210-007-0139-9

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  79 in total

1.  Structure-function analysis of protease-activated receptor 4 tethered ligand peptides. Determinants of specificity and utility in assays of receptor function.

Authors:  T R Faruqi; E J Weiss; M J Shapiro; W Huang; S R Coughlin
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

2.  Concentration-dependent dual effect of thrombin on impaired growth/apoptosis or mitogenesis in tumor cells.

Authors:  J Zain; Y Q Huang; X Feng; M L Nierodzik; J J Li; S Karpatkin
Journal:  Blood       Date:  2000-05-15       Impact factor: 22.113

3.  Proteinases and proteinase-activated receptor 2: a possible role to promote visceral hyperalgesia in rats.

Authors:  Anne-Marie Coelho; Nathalie Vergnolle; Bruno Guiard; Jean Fioramonti; Lionel Bueno
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

4.  Protease-activated receptor 3 is a second thrombin receptor in humans.

Authors:  H Ishihara; A J Connolly; D Zeng; M L Kahn; Y W Zheng; C Timmons; T Tram; S R Coughlin
Journal:  Nature       Date:  1997-04-03       Impact factor: 49.962

5.  Evidence for proteinase-activated receptor-2 (PAR-2)-mediated mitogenesis in coronary artery smooth muscle cells.

Authors:  E Bretschneider; R Kaufmann; M Braun; M Wittpoth; E Glusa; G Nowak; K Schrör
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

6.  Ligand cross-reactivity within the protease-activated receptor family.

Authors:  B D Blackhart; K Emilsson; D Nguyen; W Teng; A J Martelli; S Nystedt; J Sundelin; R M Scarborough
Journal:  J Biol Chem       Date:  1996-07-12       Impact factor: 5.157

7.  Regulation of protease-activated receptor-1 in mononuclear cells by neutrophil proteases.

Authors:  N Roche; R G Stirling; S Lim; B G Oliver; K F Chung
Journal:  Respir Med       Date:  2003-03       Impact factor: 3.415

8.  Tethered ligand-derived peptides of proteinase-activated receptor 3 (PAR3) activate PAR1 and PAR2 in Jurkat T cells.

Authors:  Kristina K Hansen; Mahmoud Saifeddine; Morley D Hollenberg
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

9.  Activation of trigeminal nociceptive neurons by parotid PAR-2 activation in rats.

Authors:  Atsufumi Kawabata; Hideki Itoh; Naoyuki Kawao; Ryotaro Kuroda; Fumiko Sekiguchi; Takashi Masuko; Koichi Iwata; Akiko Ogawa
Journal:  Neuroreport       Date:  2004-07-19       Impact factor: 1.837

10.  Proteinase-activated receptor 2-mediated potentiation of transient receptor potential vanilloid subfamily 1 activity reveals a mechanism for proteinase-induced inflammatory pain.

Authors:  Yi Dai; Tomoko Moriyama; Tomohiro Higashi; Kazuya Togashi; Kimiko Kobayashi; Hiroki Yamanaka; Makoto Tominaga; Koichi Noguchi
Journal:  J Neurosci       Date:  2004-05-05       Impact factor: 6.167

View more
  7 in total

Review 1.  Proteinases, proteinase-activated receptors (PARs) and the pathophysiology of cancer and diseases of the cardiovascular, musculoskeletal, nervous and gastrointestinal systems.

Authors:  Kristina K Hansen; Katerina Oikonomopoulou; Yang Li; Morley D Hollenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-10-19       Impact factor: 3.000

2.  Profiling gene expression induced by protease-activated receptor 2 (PAR2) activation in human kidney cells.

Authors:  Jacky Y Suen; Brooke Gardiner; Sean Grimmond; David P Fairlie
Journal:  PLoS One       Date:  2010-11-02       Impact factor: 3.240

Review 3.  Signal transduction underlying the control of urinary bladder smooth muscle tone by muscarinic receptors and beta-adrenoceptors.

Authors:  Elfaridah P Frazier; Stephan L M Peters; Alan S Braverman; Michael R Ruggieri; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-04       Impact factor: 3.000

4.  Role of mast cells and protease-activated receptor-2 in cyclooxygenase-2 expression in urothelial cells.

Authors:  Zun-Yi Wang; Peiqing Wang; Dale E Bjorling
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-08-12       Impact factor: 3.619

5.  Thrombin induces macrophage migration inhibitory factor release and upregulation in urothelium: a possible contribution to bladder inflammation.

Authors:  Pedro L Vera; Terra E Wolfe; Alexander E Braley; Katherine L Meyer-Siegler
Journal:  PLoS One       Date:  2010-12-31       Impact factor: 3.240

6.  Macrophage Migration Inhibitory Factor Mediates PAR-Induced Bladder Pain.

Authors:  Dimitrios E Kouzoukas; Katherine L Meyer-Siegler; Fei Ma; Karin N Westlund; David E Hunt; Pedro L Vera
Journal:  PLoS One       Date:  2015-05-28       Impact factor: 3.240

7.  F16357, a novel protease-activated receptor 1 antagonist, improves urodynamic parameters in a rat model of interstitial cystitis.

Authors:  N Monjotin; J Gillespie; M Farrié; B Le Grand; D Junquero; N Vergnolle
Journal:  Br J Pharmacol       Date:  2016-06-03       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.